Role of Toxins in Endophthalmitis
Role of Toxins in Endophthalmitis
批准号:
8288200
负责人:
MEREDITH GREGORY-KSANDER
金额:
$41.7万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-08-01 至 2014-06-30
关键词:
AffectAgeAnteriorAntibiotic ResistanceBacteriaBacterial ToxinsBiologyBlindnessCataract ExtractionCellsCleaved cellComplicationCrystallinsDataDecontaminationDefense MechanismsDefensinsDetectionEffectivenessEndophthalmitisEnterococcusEnterococcus faecalisEyeEye InfectionsGoalsGram-Positive BacteriaGram-Positive CocciGrowthHealthHost DefenseHumanImmune responseIn VitroInfectionInflammationInjuryIntegration Host FactorsInterventionInvadedLeadLocationMeasuresMicrobeMicrobial BiofilmsModelingOperative Surgical ProceduresOrganismOutcomePathogenesisPatientsPlayPostoperative PeriodPreventionPrevention strategyPrincipal InvestigatorProliferatingPublic HealthResearchResearch PersonnelResistanceRoleSimulateSiteStaphylococcus aureusStaphylococcus epidermidisStreptococcusStreptococcus pneumoniaeSurfaceTestingTissuesToxinVirulenceVisionVitrectomyanterior chamberantimicrobialaqueousbacterial endophthalmitiscapsuleexperienceinsightlensmembermicrobialmicroorganismnovel therapeutic interventionoral streptococcipathogenpatient populationpreventprophylacticresponseretinal apoptosisretinal damagestemtraffickingtraittreatment strategy
中文摘要
描述(由申请方提供):眼内炎是眼部手术和地球仪穿透性损伤的潜在致盲并发症。近年来,由于白内障手术病例数量的增加、患者年龄的增加以及微生物对预防措施的抗性的潜在增加以及它们在新透镜材料上形成生物膜的能力,病例数量以及比率已经上升。金黄色葡萄球菌和粪肠球菌的抗生素耐药性已成为相当大的公共卫生关注的问题。这种竞争性更新的目的是继续研究,导致细菌毒素和宿主因子在眼内炎发病机制中的特定作用。一个新的共同PI带来了更多的见解和经验的主机响应项目。中心假设是,在微生物进入前房后,细菌负荷或毒力特性在房水中挫败抗菌因子和清除机制。然后微生物使用相同或其他的毒力特性来促进通过被膜进入后节的移位。在后段,有限的玻璃体流动和抗菌防御导致压倒性的感染和视力丧失,部分原因是干扰正常的宿主细胞防御机制。该假设将通过1)确定毒力性状如何改变通过前房进入眼睛的细菌的运输; 2)确定毒力性状如何挫败先天防御,包括2-防御素抗微生物活性; 3)鉴定在前段和后段中首先响应感染的细胞;确定用于检测侵入的革兰氏阳性细菌的机制;并确定毒力性状是否影响检测或反应;以及4)确定抗细胞凋亡因子1B-晶状体蛋白在S.金黄色葡萄球菌性眼内炎,初步研究显示与视网膜损伤相关。公共卫生相关性:尽管进行了积极的抗菌治疗和手术,眼内炎仍经常导致视力丧失。这一问题因致病微生物的抗生素耐药性增加以及患者人群年龄的增加而加剧。金黄色葡萄球菌和粪肠球菌的抗生素耐药性现在是一个相当大的公共卫生问题。了解哪些细菌和宿主因素在眼内炎的发病机制中起关键作用,将允许开发新的治疗方法和预防策略,为许多接受白内障摘除术或其他眼科手术的患者保留视力。它还可能具有导致治疗和预防其他部位抗生素耐药性感染的新策略的外在价值。
英文摘要
DESCRIPTION (provided by applicant): Endophthalmitis is a potentially blinding complication of ocular surgery and globe penetrating injury. The numbers of cases, as well as the rate, has risen in recent years because of the increasing numbers of cataract surgery cases, increasing age of patients, and potentially increasing resistance of microbes to prophylactic measures and their ability to form biofilms on new lens materials. Antibiotic resistance among Staphylococcus aureus and Enterococcus faecalis has become an issue of considerable public health concern. This competing renewal aims to continue research that has led to the delineation of specific roles of bacterial toxins and host factors in the pathogenesis of endophthalmitis. A new Co-PI brings additional insights and experience on the host response to the project. The central hypothesis is that after microbes enter the anterior chamber, bacterial load or virulence traits foil antimicrobial factors and clearance mechanisms in the aqueous. Microbes then use the same or other virulence traits to promote translocation through the capsule into the posterior segment. In the posterior segment, limited vitreous flow and antimicrobial defenses lead to an overwhelming infection and vision loss stemming in part from interference with normal host cell defense mechanisms. This hypothesis will be tested by 1) Determining how virulence traits alter trafficking of bacteria entering the eye through the anterior chamber; 2) Determining how virulence traits foil innate defenses including 2-defensin antimicrobial activities; 3) Identifying the cells first to respond in the anterior and posterior segments to infection; determining the mechanism for detection of invading gram positive bacterium; and determining whether virulence traits affect detection or response; and 4) Determining how an antiapoptotic factor, 1B-crystallin, is cleaved during S. aureus endophthalmitis, which correlates in preliminary studies with retinal damage. PUBLIC HEALTH RELEVANCE: Endophthalmitis frequently leads to vision loss, despite aggressive antimicrobial therapy and surgery. This problem is exacerbated by increasing antibiotic resistance of the offending microbe, and the increasing age of the patient population. Antibiotic resistance among Staphylococcus aureus and Enterococcus faecalis is now an issue of considerable public health concern. Understanding which bacterial and host factors play critical roles in the pathogenesis of endophthalmitis will permit new therapeutic approaches and preventive strategies to be developed, preserving vision for many patients undergoing cataract extraction or other ocular surgery. It may also have the extrinsic value of leading to new strategies for the treatment and prevention of antibiotic resistant infection at other sites as well.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1078/1438-4221-00301
发表时间:
2004
期刊:
International journal of medical microbiology : IJMM
影响因子:
--
作者:
[N. Shankar;P. Coburn;C. Pillar;Wolfgang Haas;M. Gilmore]
通讯作者:
N. Shankar;P. Coburn;C. Pillar;Wolfgang Haas;M. Gilmore
A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin.
一种与毒素激活无关的新型自我保护方法,赋予对粪肠球菌溶细胞素的杀菌作用的免疫力。
DOI:
10.1128/iai.67.7.3339-3347.1999
发表时间:
1999
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Coburn,PS, Hancock,LE, Booth,MC, Gilmore,MS]
通讯作者:
Gilmore,MS
DOI:
10.1371/journal.pone.0110872
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Sadaka A, Palmer K, Suzuki T, Gilmore MS]
通讯作者:
Gilmore MS
Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice.
粪肠球菌溶细胞素对小鼠肠道内敏感肠球菌的生长没有影响。
DOI:
10.1093/infdis/172.1.273
发表时间:
1995
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
[Huycke,MM, Joyce,WA, Gilmore,MS]
通讯作者:
Gilmore,MS
DOI:
--
发表时间:
1995-08
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[M. C. Booth;R. V. Atkuri;S. Nanda;J. Iandolo;Michael S. Gilmore]
通讯作者:
M. C. Booth;R. V. Atkuri;S. Nanda;J. Iandolo;Michael S. Gilmore
共 14 条
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10374484
-
项目类别:
-
资助金额:$61.96万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10867990
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10550147
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10320063
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10115860
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10527371
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma.
-
批准号:9919567
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2019
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of vascular leakage in age related macular degeneration
-
批准号:8385057
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of vascular leakage in age related macular degeneration
-
批准号:8534134
-
项目类别:
-
资助金额:$21.67万
-
财政年份:2012
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8237645
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8389866
-
项目类别:
-
资助金额:$46.08万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8581345
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7534765
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:6857036
-
项目类别:
-
资助金额:$41.7万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7342074
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:6986096
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7171789
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6525174
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2002
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6641246
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2002
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6405260
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: